BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 16010241)

  • 1. Transcriptional regulation of hepatobiliary transport systems in health and disease: implications for a rationale approach to the treatment of intrahepatic cholestasis.
    Wagner M; Trauner M
    Ann Hepatol; 2005; 4(2):77-99. PubMed ID: 16010241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular regulation of hepatobiliary transport systems: clinical implications for understanding and treating cholestasis.
    Trauner M; Wagner M; Fickert P; Zollner G
    J Clin Gastroenterol; 2005 Apr; 39(4 Suppl 2):S111-24. PubMed ID: 15758646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of cholestasis.
    Zollner G; Trauner M
    Wien Med Wochenschr; 2006 Jul; 156(13-14):380-5. PubMed ID: 16937039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatobiliary ABC transporters: physiology, regulation and implications for disease.
    Jonker JW; Stedman CA; Liddle C; Downes M
    Front Biosci (Landmark Ed); 2009 Jun; 14(13):4904-20. PubMed ID: 19482594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic cholestasis: lessons from the molecular physiology of bile formation.
    Jansen PL; Müller M
    Can J Gastroenterol; 2000 Mar; 14(3):233-8. PubMed ID: 10758420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Principles of hepatic organic anion transporter regulation during cholestasis, inflammation and liver regeneration.
    Geier A; Wagner M; Dietrich CG; Trauner M
    Biochim Biophys Acta; 2007 Mar; 1773(3):283-308. PubMed ID: 17291602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear receptor regulation of the adaptive response of bile acid transporters in cholestasis.
    Wagner M; Zollner G; Trauner M
    Semin Liver Dis; 2010 May; 30(2):160-77. PubMed ID: 20422498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alisol B 23-acetate protects against ANIT-induced hepatotoxity and cholestasis, due to FXR-mediated regulation of transporters and enzymes involved in bile acid homeostasis.
    Meng Q; Chen XL; Wang CY; Liu Q; Sun HJ; Sun PY; Huo XK; Liu ZH; Yao JH; Liu KX
    Toxicol Appl Pharmacol; 2015 Mar; 283(3):178-86. PubMed ID: 25655198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New molecular insights into the mechanisms of cholestasis.
    Wagner M; Zollner G; Trauner M
    J Hepatol; 2009 Sep; 51(3):565-80. PubMed ID: 19595470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetics of hepatocellular transporters.
    Pauli-Magnus C; Meier PJ
    Pharmacogenetics; 2003 Apr; 13(4):189-98. PubMed ID: 12668915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of farnesoid X receptor in cholestasis.
    Yuan ZQ; Li KW
    J Dig Dis; 2016 Aug; 17(8):501-509. PubMed ID: 27383832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice.
    Wagner M; Halilbasic E; Marschall HU; Zollner G; Fickert P; Langner C; Zatloukal K; Denk H; Trauner M
    Hepatology; 2005 Aug; 42(2):420-30. PubMed ID: 15986414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Insights in Genetic Cholestasis: From Molecular Mechanisms to Clinical Implications.
    Sticova E; Jirsa M; Pawłowska J
    Can J Gastroenterol Hepatol; 2018; 2018():2313675. PubMed ID: 30148122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation mediated down-regulation of hepatobiliary transporters contributes to intrahepatic cholestasis and liver damage in murine biliary atresia.
    Yang H; Plösch T; Lisman T; Gouw AS; Porte RJ; Verkade HJ; Hulscher JB
    Pediatr Res; 2009 Oct; 66(4):380-5. PubMed ID: 19581828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular transporters and cholestasis.
    Pauli-Magnus C; Meier PJ
    J Clin Gastroenterol; 2005 Apr; 39(4 Suppl 2):S103-10. PubMed ID: 15758645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding and controlling hepatobiliary function.
    Elferink RP
    Best Pract Res Clin Gastroenterol; 2002 Dec; 16(6):1025-34. PubMed ID: 12473305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear hormone receptor-dependent regulation of hepatic transporters and their role in the adaptive response in cholestasis.
    Stahl S; Davies MR; Cook DI; Graham MJ
    Xenobiotica; 2008 Jul; 38(7-8):725-77. PubMed ID: 18668429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations.
    Zollner G; Marschall HU; Wagner M; Trauner M
    Mol Pharm; 2006; 3(3):231-51. PubMed ID: 16749856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatobiliary transporters and drug-induced cholestasis.
    Pauli-Magnus C; Meier PJ
    Hepatology; 2006 Oct; 44(4):778-87. PubMed ID: 17006912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive familial intrahepatic cholestasis type 1.
    Paulusma CC; Elferink RP; Jansen PL
    Semin Liver Dis; 2010 May; 30(2):117-24. PubMed ID: 20422494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.